462 Works
Additional file 3 of PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients
Daniele Giardiello, Maartje J. Hooning, Michael Hauptmann, Renske Keeman, B. A. M. Heemskerk-Gerritsen, Heiko Becher, Carl Blomqvist, Stig E. Bojesen, Manjeet K. Bolla, Nicola J. Camp, Kamila Czene, Peter Devilee, Diana M. Eccles, Peter A. Fasching, Jonine D. Figueroa, Henrik Flyger, Montserrat García-Closas, Christopher A. Haiman, Ute Hamann, John L. Hopper, Anna Jakubowska, Floor E. Leeuwen, Annika Lindblom, Jan Lubiński, Sara Margolin … & Marjanka K. Schmidt
Additional file 1: Table S3. Patient and primary breast cancer characteristics per study.
PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients
Daniele Giardiello, Maartje J. Hooning, Michael Hauptmann, Renske Keeman, B. A. M. Heemskerk-Gerritsen, Heiko Becher, Carl Blomqvist, Stig E. Bojesen, Manjeet K. Bolla, Nicola J. Camp, Kamila Czene, Peter Devilee, Diana M. Eccles, Peter A. Fasching, Jonine D. Figueroa, Henrik Flyger, Montserrat García-Closas, Christopher A. Haiman, Ute Hamann, John L. Hopper, Anna Jakubowska, Floor E. Leeuwen, Annika Lindblom, Jan Lubiński, Sara Margolin … & Marjanka K. Schmidt
Abstract Background Prediction of contralateral breast cancer (CBC) risk is challenging due to moderate performances of the known risk factors. We aimed to improve our previous risk prediction model (PredictCBC) by updated follow-up and including additional risk factors. Methods We included data from 207,510 invasive breast cancer patients participating in 23 studies. In total, 8225 CBC events occurred over a median follow-up of 10.2 years. In addition to the previously included risk factors, PredictCBC-2.0 included...
PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients
Daniele Giardiello, Maartje J. Hooning, Michael Hauptmann, Renske Keeman, B. A. M. Heemskerk-Gerritsen, Heiko Becher, Carl Blomqvist, Stig E. Bojesen, Manjeet K. Bolla, Nicola J. Camp, Kamila Czene, Peter Devilee, Diana M. Eccles, Peter A. Fasching, Jonine D. Figueroa, Henrik Flyger, Montserrat García-Closas, Christopher A. Haiman, Ute Hamann, John L. Hopper, Anna Jakubowska, Floor E. Leeuwen, Annika Lindblom, Jan Lubiński, Sara Margolin … & Marjanka K. Schmidt
Abstract Background Prediction of contralateral breast cancer (CBC) risk is challenging due to moderate performances of the known risk factors. We aimed to improve our previous risk prediction model (PredictCBC) by updated follow-up and including additional risk factors. Methods We included data from 207,510 invasive breast cancer patients participating in 23 studies. In total, 8225 CBC events occurred over a median follow-up of 10.2 years. In addition to the previously included risk factors, PredictCBC-2.0 included...
Additional file 2 of Study design of an interdisciplinary and participatory nature-based palliative rehabilitation intervention in a Danish nursing home for people with severe dementia
Tanja Schmidt, Marie Christoffersen Gramkow, Dorthe Varning Poulsen, Louise Holm Miller, Lene Wermuth & Ulrika K. Stigsdotter
Additional file 2. (Staff burnout questionnaire): Modified questionnaire on staff burnout, based on Pine’s scale and additional questions on garden use and attitudes.
Study design of an interdisciplinary and participatory nature-based palliative rehabilitation intervention in a Danish nursing home for people with severe dementia
Tanja Schmidt, Marie Christoffersen Gramkow, Dorthe Varning Poulsen, Louise Holm Miller, Lene Wermuth & Ulrika K. Stigsdotter
Abstract Background A limited amount of research has examined how nature-based palliative rehabilitation can be implemented in nursing homes for people with dementia, even though evidence suggests that these gardens are underused. This paper will present the study protocol of an intervention study co-designed in an interdisciplinary collaboration with a nursing home for people with dementia, to develop a tailored nature-based palliative rehabilitation program to increase qualified use of garden with the purpose of promoting...
Designing a process evaluation of an integrated workplace intervention to reduce sickness absence.pdf
Lene Rasmussen, Maj Britt Dahl Nielsen, Anne Helene Garde & Jesper Kristiansen
Aim: To date results from interventions to prevent or reduce sickness absence have had inconclusive, unsustainable or small effects. One reason may be that the effects of such interventions are affected by contextual factors in the workplace. These contextual factors can be identified through a process evaluation examining the implementation process. The aim of this paper is to present the design of a process evaluation of the implementation of a complex intervention called the Sickness...
Humoral and Cellular Immunogenicity and Efficacy of a Coxsackievirus A10 Vaccine in Mice
Huan-Huan An, Meng Li, Rui-Lun Liu, Jie Wu, Sheng-Li Meng, Jing Guo, Ze-Jun Wang, Sha-Sha Qian & Shuo Shen
Coxsackievirus A10 (CV-A10) has become one of the major pathogens of hand, foot and mouth disease (HFMD), and studies on the vaccine and animal model of CV-A10 are still far from complete. Our study used a mouse adapted CV-A10 strain, which was lethal for 14-day-old mice, to develop an infected mouse model. Then this model was employed to establish an actively immunized-challenged mouse model to evaluate the efficacy of a formaldehyde-inactivated CV-A10 vaccine, which was...
sj-docx-1-aor-10.1177_00034894221139362 – Supplemental material for Clinical Presentation and Outcome of Sinonasal Extraosseous Plasmacytoma in Denmark: A Nationwide Cohort From 1980 to 2017
Patrick René Gerhard Eriksen, Elham Khakbaz, Erik Clasen-Linde, Peter de Nully Brown, Laura Haunstrup, Mette Christoffersen, Peter Asdahl, Troels Møller Thomsen, Jonas Gerner-Rasmussen, Steffen Heegaard & Christian von Buchwald
Supplemental material, sj-docx-1-aor-10.1177_00034894221139362 for Clinical Presentation and Outcome of Sinonasal Extraosseous Plasmacytoma in Denmark: A Nationwide Cohort From 1980 to 2017 by Patrick René Gerhard Eriksen, Elham Khakbaz, Erik Clasen-Linde, Peter de Nully Brown, Laura Haunstrup, Mette Christoffersen, Peter Asdahl, Troels Møller Thomsen, Jonas Gerner-Rasmussen, Steffen Heegaard and Christian von Buchwald in Annals of Otology, Rhinology & Laryngology
Additional file 2 of Time trends of cardiovascular risk management in type 1 diabetes - nationwide analyses of real-life data
Hanan Amadid, Kim Katrine Bjerring Clemmensen, Dorte Vistisen, Frederik Persson & Marit Eika Jørgensen
Additional file 2: Figure S2. Proportions within blood pressure thresholds among the type 1 diabetes population by anithypertensive drug use.
Additional file 3 of Time trends of cardiovascular risk management in type 1 diabetes - nationwide analyses of real-life data
Hanan Amadid, Kim Katrine Bjerring Clemmensen, Dorte Vistisen, Frederik Persson & Marit Eika Jørgensen
Additional file 3: Table S1. Risk factors and corresponding Nomenclature for Properties and Units codes.
Additional file 4 of Time trends of cardiovascular risk management in type 1 diabetes - nationwide analyses of real-life data
Hanan Amadid, Kim Katrine Bjerring Clemmensen, Dorte Vistisen, Frederik Persson & Marit Eika Jørgensen
Additional file 4: Table S2. International Classification of Diseases 10th revision (ICD-10) codes and Danish procedure codes used to define micro- and macrovascular complications.
Additional file 2 of Time trends of cardiovascular risk management in type 1 diabetes - nationwide analyses of real-life data
Hanan Amadid, Kim Katrine Bjerring Clemmensen, Dorte Vistisen, Frederik Persson & Marit Eika Jørgensen
Additional file 2: Figure S2. Proportions within blood pressure thresholds among the type 1 diabetes population by anithypertensive drug use.
Additional file 1 of Seroprevalence of SARS-CoV-2 antibodies among children and adolescents recruited in a malariometric survey in north-eastern Tanzania July 2021
Eric Lyimo, Cyrielle Fougeroux, Anangisye Malabeja, Joyce Mbwana, Paul M. Hayuma, Edwin Liheluka, Louise Turner, Samwel Gesase, Thomas Lavstsen, John P. A. Lusingu, Daniel T. R. Minja & Christian W. Wang
Additional file 1. Baseline characteristics of the study populations from before the COVID-19 pandemic.
Additional file 1 of Seroprevalence of SARS-CoV-2 antibodies among children and adolescents recruited in a malariometric survey in north-eastern Tanzania July 2021
Eric Lyimo, Cyrielle Fougeroux, Anangisye Malabeja, Joyce Mbwana, Paul M. Hayuma, Edwin Liheluka, Louise Turner, Samwel Gesase, Thomas Lavstsen, John P. A. Lusingu, Daniel T. R. Minja & Christian W. Wang
Additional file 1. Baseline characteristics of the study populations from before the COVID-19 pandemic.
Seroprevalence of SARS-CoV-2 antibodies among children and adolescents recruited in a malariometric survey in north-eastern Tanzania July 2021
Eric Lyimo, Cyrielle Fougeroux, Anangisye Malabeja, Joyce Mbwana, Paul M. Hayuma, Edwin Liheluka, Louise Turner, Samwel Gesase, Thomas Lavstsen, John P. A. Lusingu, Daniel T. R. Minja & Christian W. Wang
Abstract Background African countries stand out globally as the region seemingly least affected by the COVID-19 pandemic, caused by the virus SARS-CoV-2. Besides a younger population and potential pre-existing immunity to a SARS-CoV-2-like virus, it has been hypothesized that co-infection or recent history of Plasmodium falciparum malaria may be protective of COVID-19 severity and mortality. The number of COVID-19 cases and deaths, however, may be vastly undercounted. Very little is known about the extent to...
Additional file 2 of Identification of a window of androgen sensitivity for somatic cell function in human fetal testis cultured ex vivo
Malene Lundgaard Riis, Gabriele Matilionyte, John E. Nielsen, Cecilie Melau, David Greenald, Kristine Juul Hare, Lea Langhoff Thuesen, Eva Dreisler, Kasper Aaboe, Pia Tutein Brenøe, Anna-Maria Andersson, Jakob Albrethsen, Hanne Frederiksen, Ewa Rajpert-De Meyts, Anders Juul, Rod T. Mitchell & Anne Jørgensen
Additional file 2: Figure S2. Effects of manipulating androgen production in ex vivo cultured human fetal testis tissue on expression of the Sertoli cell marker SOX9. Expression pattern of the Sertoli cell marker SOX9 in fetal testis samples treated with ketoconazole (10-6 M) and hCG (1 IU/ml) for two weeks in ex vivo culture. Images representative for the expression in each age-group and treatment. Counterstaining with Mayer haematoxylin, scale bar corresponds to 50 µm.
Additional file 3 of Identification of a window of androgen sensitivity for somatic cell function in human fetal testis cultured ex vivo
Malene Lundgaard Riis, Gabriele Matilionyte, John E. Nielsen, Cecilie Melau, David Greenald, Kristine Juul Hare, Lea Langhoff Thuesen, Eva Dreisler, Kasper Aaboe, Pia Tutein Brenøe, Anna-Maria Andersson, Jakob Albrethsen, Hanne Frederiksen, Ewa Rajpert-De Meyts, Anders Juul, Rod T. Mitchell & Anne Jørgensen
Additional file 3: Figure S3. Effects of reduced androgen exposure via blocking of the androgen receptor in ex vivo culture of human fetal testes. Quantification of A) testosterone B) androstenedione and C) DHEAS secretion by ex vivo cultured fetal testis tissue from GW 7-12 following treatment with flutamide (10-6 M) and ketoconazole (10-6 M) for 14 days. Media were collected every 48 hours throughout the 14-day culture period and were pooled for each individual tissue...
Bakker, søer og floddale: Istiden satte dramatiske fodspor i landskabet
Michael Houmark-NielsenKlima-berømtheder på sociale medier kan skabe engagement frem for klimaangst
Helle Kannik HaastrupAdditional file 1 of Pan-cancer analysis of pre-diagnostic blood metabolite concentrations in the European Prospective Investigation into Cancer and Nutrition
Marie Breeur, Pietro Ferrari, Laure Dossus, Mazda Jenab, Mattias Johansson, Sabina Rinaldi, Ruth C. Travis, Mathilde His, Tim J. Key, Julie A. Schmidt, Kim Overvad, Anne Tjønneland, Cecilie Kyrø, Joseph A. Rothwell, Nasser Laouali, Gianluca Severi, Rudolf Kaaks, Verena Katzke, Matthias B. Schulze, Fabian Eichelmann, Domenico Palli, Sara Grioni, Salvatore Panico, Rosario Tumino, Carlotta Sacerdote … & Vivian Viallon
Additional file 1. Supplementary material regarding (i) the definition of cancer cases for HCC, GBC, Adv.PrC and Loc.PrC; (ii) the definition and implementation of the data-shared lasso; (iii) the models used to derive point estimates and confidence intervals from the model selected by the data-shared lasso; and (iv) the univariate analysis conducted for comparison.
Cardiovascular risk factors, radiation therapy, and myocardial infarction among lymphoma survivors
Talya Salz, Emily C. Zabor, Peter De Nully Brown, Susanne Oksbjerg Dalton, Nirupa J. Raghunathan, Matthew J. Matasar, Richard Steingart, Henrik Hjalgrim, Lena Specht, Andrew J. Vickers, Kevin C. Oeffinger & Christoffer Johansen
Mediastinal radiation is associated with increased risk of myocardial infarction (MI) among non-Hodgkin lymphoma (NHL) survivors. To evaluate how preexisting cardiovascular risk factors (CVRFs) modify the association of mediastinal radiation and MI among a national population of NHL survivors with a range of CVRFs. Using Danish registries, we identified adults diagnosed with lymphoma 2000–2010. We assessed MI from one year after diagnosis through 2016. We ascertained CVRFs (hypertension, dyslipidemia, and diabetes), vascular disease, and intrinsic...
Data for: Epistatic effects between amino acid insertions and substitutions mediate toxin-resistance of vertebrate Na+, K+-ATPases
Shabnam Mohammadi, Halil Özdemir, Pemra Ozbek, Fidan Sumbul, Josefin Stiller, Yuan Deng, Andrew Crawford, Hannah Rowland, Jay Storz, Peter Andolfatto & Susanne Dobler
The recurrent evolution of resistance to cardiotonic steroids (CTS) across diverse animals most frequently involves convergent amino-acid substitutions in the H1-H2 extracellular loop of Na+, K+-ATPase (NKA). Previous work revealed that hystricognath rodents (e.g. chinchilla) and pterocliform birds (sandgrouse) have convergently evolved amino-acid insertions in the H1-H2 loop, but their functional significance was not known. Using protein engineering, we show that these insertions have distinct effects on CTS resistance in homologs of each of the...
sj-pdf-1-pmj-10.1177_02692163221142950 – Supplemental material for Healthcare use and healthcare costs for patients with advanced cancer; the international ACTION cluster-randomised trial on advance care planning
Ida J Korfage, Suzanne Polinder, Nancy Preston, Johannes JM van Delden, Sandra (A)JLM Geraerds, Lesley Dunleavy, Kristof Faes, Guido Miccinesi, Giulia Carreras, Caroline Moeller Arnfeldt, Marijke C Kars, Giuseppe Lippi, Urska Lunder, Ceu Mateus, Kristian Pollock, Luc Deliens, Mogens Groenvold, Agnes van der Heide & Judith AC Rietjens
Supplemental material, sj-pdf-1-pmj-10.1177_02692163221142950 for Healthcare use and healthcare costs for patients with advanced cancer; the international ACTION cluster-randomised trial on advance care planning by Ida J Korfage, Suzanne Polinder, Nancy Preston, Johannes JM van Delden, A)JLM Geraerds, Lesley Dunleavy, Kristof Faes, Guido Miccinesi, Giulia Carreras, Caroline Moeller Arnfeldt, Marijke C Kars, Giuseppe Lippi, Urska Lunder, Ceu Mateus, Kristian Pollock, Luc Deliens, Mogens Groenvold, Agnes van der Heide and Judith AC Rietjens in Palliative Medicine
sj-pdf-2-pmj-10.1177_02692163221142950 – Supplemental material for Healthcare use and healthcare costs for patients with advanced cancer; the international ACTION cluster-randomised trial on advance care planning
Ida J Korfage, Suzanne Polinder, Nancy Preston, Johannes JM van Delden, Sandra (A)JLM Geraerds, Lesley Dunleavy, Kristof Faes, Guido Miccinesi, Giulia Carreras, Caroline Moeller Arnfeldt, Marijke C Kars, Giuseppe Lippi, Urska Lunder, Ceu Mateus, Kristian Pollock, Luc Deliens, Mogens Groenvold, Agnes van der Heide & Judith AC Rietjens
Supplemental material, sj-pdf-2-pmj-10.1177_02692163221142950 for Healthcare use and healthcare costs for patients with advanced cancer; the international ACTION cluster-randomised trial on advance care planning by Ida J Korfage, Suzanne Polinder, Nancy Preston, Johannes JM van Delden, A)JLM Geraerds, Lesley Dunleavy, Kristof Faes, Guido Miccinesi, Giulia Carreras, Caroline Moeller Arnfeldt, Marijke C Kars, Giuseppe Lippi, Urska Lunder, Ceu Mateus, Kristian Pollock, Luc Deliens, Mogens Groenvold, Agnes van der Heide and Judith AC Rietjens in Palliative Medicine
sj-pdf-3-pmj-10.1177_02692163221142950 – Supplemental material for Healthcare use and healthcare costs for patients with advanced cancer; the international ACTION cluster-randomised trial on advance care planning
Ida J Korfage, Suzanne Polinder, Nancy Preston, Johannes JM van Delden, Sandra (A)JLM Geraerds, Lesley Dunleavy, Kristof Faes, Guido Miccinesi, Giulia Carreras, Caroline Moeller Arnfeldt, Marijke C Kars, Giuseppe Lippi, Urska Lunder, Ceu Mateus, Kristian Pollock, Luc Deliens, Mogens Groenvold, Agnes van der Heide & Judith AC Rietjens
Supplemental material, sj-pdf-3-pmj-10.1177_02692163221142950 for Healthcare use and healthcare costs for patients with advanced cancer; the international ACTION cluster-randomised trial on advance care planning by Ida J Korfage, Suzanne Polinder, Nancy Preston, Johannes JM van Delden, A)JLM Geraerds, Lesley Dunleavy, Kristof Faes, Guido Miccinesi, Giulia Carreras, Caroline Moeller Arnfeldt, Marijke C Kars, Giuseppe Lippi, Urska Lunder, Ceu Mateus, Kristian Pollock, Luc Deliens, Mogens Groenvold, Agnes van der Heide and Judith AC Rietjens in Palliative Medicine